PTC THERAPEUTICS, INC. — Director's Dealing 2015

Jan 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-12-31

Reporting Person: Hirawat Claudia de Oliveira Ribeiro (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-31	Common Stock	M	417	$10.85	Acquired	39417	Direct
2014-12-31	Common Stock	S	417	$52.39	Disposed	39000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-31	Stock Option (right to buy)	$10.85	M	417	Disposed	2023-05-15	Common Stock (417)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	194	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.27 to $52.60 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: Pursuant to the Separation and General Release Agreement dated December 16, 2014 between the Reporting Person and the Issuer, the remaining options will vest on January 16, 2015.